NORTEC DEVELOPMENT ASSOCIATES, INC. – Trademark Portfolio
Entity Type: 03
NORTEC DEVELOPMENT ASSOCIATES, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CPS TECHNOLOGY. The owner is based in Ramsey, NJ.
100 Spear Road
Ramsey, NJ 07446
Showing of trademarks Trademarks
Trademark Classifications
NORTEC DEVELOPMENT ASSOCIATES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NORTEC DEVELOPMENT ASSOCIATES, INC. have?
NORTEC DEVELOPMENT ASSOCIATES, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does NORTEC DEVELOPMENT ASSOCIATES, INC. file in?
NORTEC DEVELOPMENT ASSOCIATES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are NORTEC DEVELOPMENT ASSOCIATES, INC.'s most well-known trademarks?
NORTEC DEVELOPMENT ASSOCIATES, INC.'s registered trademark portfolio includes well-known marks such as CPS TECHNOLOGY. These are among 1 currently registered trademark in the portfolio.
What is NORTEC DEVELOPMENT ASSOCIATES, INC.'s trademark registration success rate?
NORTEC DEVELOPMENT ASSOCIATES, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.